North American blastomycosis is caused by Blastomyces dermatitidis. This organism grows in tissue as a thickwalled yeast form, 8 mm to 15-20 mm in diameter with broad based budding. 1 Multiple nuclei can be seen in well fixed tissue. 1 In endemic areas of this country, the organism has been isolated from soil. 1 With the exception of accidental laboratory inoculations, infections are probably primarily pulmonary. However, pulmonary involvement may not be apparent when secondary lesions appear in the skin, bone, genitourinary tract, or elsewhere. 1 Although blastomycosis is one of the four major endemic mycoses in North America, including histoplasmosis, cryptococcosis, and coccidioidomycosis, not until recently has it been recognized as an opportunistic infection in immunocompromised hosts. 2, 3 Intact cellular immunity is important in the prevention of progressive blastomycosis; however, adequate neutrophil function also appears important in the host response. [4] [5] [6] Immunocompromised patient populations in which cases of blastomycosis have been reported have included patients on chronic glucocorticosteroids, patients who have had solid organ transplants, patients with lymphoid malignancies, and patients with HIV-1 disease.
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We present an additional case of systemic blastomycosis in a cardiac transplant patient. Giant yeast forms, which have previously only been reported within the lung in two other patients, were see within the skin in this patient. 8, 9 Case report The patient was a 14-year-old white male who had received a donor heart transplant 36 days earlier. The patient's medications included tacrolimus, mycophenolate mofetil, and prednisone. Over approximately a 48-h period the patient experienced increasing shortness of breath, with a low-grade fever. Chest X-ray was performed and showed a diffuse interstitial infiltrate. Sputum and blood were obtained for bacterial, mycobacterial, and fungal cultures, and the patient was started on antibiotics including tobramycin and cefuroxime.
Approximately 48 h later, the patient's condition had deteriorated and he developed diffuse erythematous dermal papules over the trunk and proximal extremities. Biopsy material was obtained and sent for culture as well for routine histologic examination. 
Biopsy findings
The biopsy specimen showed a relatively mild inflammatory infiltrate. However, medium size vessels in the mid to lower reticular dermis were packed with yeast forms (Fig. 1) . In addition, these organism were immediately surrounding the vessels with an associated mild mixed inflammatory infiltrate. These yeast forms had thick capsules and multiple nuclei. They varied in size from approximately 20 mm to over 40 mm in diameter, and showed occasional broad-based budding forms (Figs. 2 and 3) . Rare organisms were present that showed binary fission (Fig. 3 ).
Although the patient was then started on amphotericin B with a presumptive diagnosis of blastomycosis, he showed a progressive downhill course and died 12 days later. The organism was later confirmed as B. dermatitidis by standard culture methods. 617 Fig. 3. As Fig. 2 , but at magnification ¿288.
Discussion
In immunocompromised patients, blastomycosis is often more aggressive than in immunocompetent hosts. 3, 7 Over 30% of the reported immunocompromised patients have died secondary to their blastomycosis, and they usually die relatively rapidly.
3,7 A high index of suspicion for possible development of B. dermatitidis infection is difficult because of the lack of reliable skin and serologic tests needed for establishment of prior exposure in immunosuppressed patients. 3 In addition, a specific diagnosis may be delayed, even if tissue is obtained, because of the wide variation in the morphology of Blastomyces in tissue.
Some variation in size, shape, staining, and wall thickness of yeast forms of B. dermatitidis can occur in different fields of the same specimen in immunocompetent hosts. 10, 11 However, the greatest variation in yeast forms are seen in immunosuppressed patients, and in these patients there may also be hyphal forms present. [8] [9] [10] [11] [12] . To our knowledge this is the first case of giant yeast forms in the skin of B. dermatitidis reported. What specific immunologic and/or inflammatory factors are playing a role in the variable morphologic patterns seen with deep fungal infections is not known. However, with an ever-expanding group of immune and inflammatory modulators in use and in development for autoimmune disease, malignancies, and transplantation, we can expect to seen even more atypical forms.
